ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients (TIMELY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01415011
Recruitment Status : Active, not recruiting
First Posted : August 11, 2011
Last Update Posted : May 10, 2018
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
University College, London

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : August 2015
  Estimated Study Completion Date : September 2018